Retardation or Acceleration of Diabetes in NOD/Lt Mice Mediated by Intrathymic Administration of Candidate β-Cell Antigens
Marina Ćetković-Cvrlje(Jackson Laboratory), Edward H. Leiter(Jackson Laboratory), Ivan Gerling(University of Tennessee Health Science Center), John F. Elliott(Diabetes & Endocrine Associates), Andrew Muir(Children's Medical Center), Mark A. Atkinson(University of Florida)
Cited by 79
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k